 Randi Johnson
Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 19 | 2024 | 3624 | 1.870 |
Why?
| | Islets of Langerhans | 10 | 2024 | 790 | 1.860 |
Why?
| | DNA Methylation | 7 | 2024 | 605 | 1.770 |
Why?
| | Autoimmunity | 13 | 2024 | 860 | 1.460 |
Why?
| | Diet | 6 | 2021 | 1204 | 1.100 |
Why?
| | Metabolomics | 4 | 2024 | 599 | 0.790 |
Why?
| | Autoantibodies | 7 | 2024 | 1465 | 0.780 |
Why?
| | Dinoprostone | 1 | 2022 | 187 | 0.740 |
Why?
| | Genetic Predisposition to Disease | 6 | 2023 | 2267 | 0.740 |
Why?
| | Lipid Metabolism | 2 | 2024 | 493 | 0.700 |
Why?
| | Asthma | 3 | 2024 | 2219 | 0.690 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 356 | 0.680 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2021 | 169 | 0.640 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 104 | 0.630 |
Why?
| | Adolescent Health | 1 | 2019 | 39 | 0.610 |
Why?
| | Glutens | 4 | 2021 | 57 | 0.540 |
Why?
| | Schools | 1 | 2019 | 439 | 0.490 |
Why?
| | Rural Population | 1 | 2019 | 512 | 0.470 |
Why?
| | Precision Medicine | 3 | 2023 | 384 | 0.470 |
Why?
| | Sexual Behavior | 1 | 2019 | 483 | 0.460 |
Why?
| | Risk Factors | 11 | 2023 | 9767 | 0.450 |
Why?
| | Adolescent Behavior | 1 | 2019 | 505 | 0.440 |
Why?
| | Case-Control Studies | 7 | 2024 | 3342 | 0.430 |
Why?
| | Health Behavior | 1 | 2019 | 740 | 0.420 |
Why?
| | Nasal Mucosa | 2 | 2024 | 107 | 0.400 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2437 | 0.380 |
Why?
| | Biological Specimen Banks | 2 | 2023 | 96 | 0.380 |
Why?
| | Child, Preschool | 13 | 2024 | 10450 | 0.360 |
Why?
| | Child | 17 | 2024 | 20805 | 0.360 |
Why?
| | Seroconversion | 2 | 2021 | 46 | 0.350 |
Why?
| | Female | 23 | 2024 | 68510 | 0.310 |
Why?
| | Eating | 3 | 2021 | 367 | 0.310 |
Why?
| | CpG Islands | 3 | 2023 | 152 | 0.300 |
Why?
| | Humans | 31 | 2024 | 129116 | 0.290 |
Why?
| | Disease Progression | 4 | 2024 | 2613 | 0.290 |
Why?
| | Male | 18 | 2024 | 63194 | 0.280 |
Why?
| | Genome-Wide Association Study | 3 | 2024 | 1337 | 0.270 |
Why?
| | Celiac Disease | 2 | 2020 | 287 | 0.260 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2024 | 25 | 0.230 |
Why?
| | Oxylipins | 2 | 2023 | 31 | 0.220 |
Why?
| | Diet Surveys | 2 | 2021 | 92 | 0.220 |
Why?
| | Colorado | 3 | 2023 | 4394 | 0.210 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.210 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1210 | 0.210 |
Why?
| | Epigenesis, Genetic | 3 | 2024 | 616 | 0.190 |
Why?
| | Pregnancy | 5 | 2024 | 6375 | 0.190 |
Why?
| | Eicosanoids | 1 | 2022 | 55 | 0.190 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 45 | 0.190 |
Why?
| | Pregnancy Trimester, Third | 1 | 2021 | 108 | 0.180 |
Why?
| | Infant | 8 | 2021 | 8992 | 0.180 |
Why?
| | Breast Feeding | 2 | 2021 | 422 | 0.170 |
Why?
| | Dietary Sucrose | 1 | 2020 | 48 | 0.170 |
Why?
| | Adolescent | 8 | 2024 | 20301 | 0.170 |
Why?
| | Sugars | 1 | 2020 | 37 | 0.170 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 137 | 0.170 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 568 | 0.160 |
Why?
| | Phospholipids | 1 | 2021 | 209 | 0.160 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 2065 | 0.160 |
Why?
| | Prospective Studies | 5 | 2023 | 7079 | 0.150 |
Why?
| | Thinness | 1 | 2019 | 90 | 0.150 |
Why?
| | Early Diagnosis | 1 | 2019 | 236 | 0.150 |
Why?
| | Dietary Proteins | 1 | 2019 | 128 | 0.150 |
Why?
| | Pregnancy in Adolescence | 1 | 2019 | 81 | 0.150 |
Why?
| | Postpartum Period | 1 | 2021 | 330 | 0.150 |
Why?
| | Chromatography, Liquid | 1 | 2019 | 375 | 0.150 |
Why?
| | Vulnerable Populations | 1 | 2019 | 157 | 0.140 |
Why?
| | Guatemala | 1 | 2019 | 311 | 0.140 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2024 | 563 | 0.140 |
Why?
| | Child Health | 1 | 2019 | 146 | 0.140 |
Why?
| | Pilot Projects | 1 | 2022 | 1567 | 0.130 |
Why?
| | Health Surveys | 1 | 2019 | 492 | 0.130 |
Why?
| | Child Behavior | 1 | 2019 | 236 | 0.130 |
Why?
| | Vitamin D | 1 | 2019 | 381 | 0.130 |
Why?
| | Follow-Up Studies | 3 | 2019 | 4915 | 0.130 |
Why?
| | Risk-Taking | 1 | 2019 | 348 | 0.130 |
Why?
| | Environmental Exposure | 1 | 2020 | 464 | 0.120 |
Why?
| | Pregnancy, Unplanned | 1 | 2015 | 45 | 0.120 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1004 | 0.120 |
Why?
| | Infant, Low Birth Weight | 1 | 2015 | 135 | 0.120 |
Why?
| | Overweight | 1 | 2019 | 526 | 0.110 |
Why?
| | Contraceptive Agents, Female | 1 | 2015 | 78 | 0.110 |
Why?
| | Safety-net Providers | 1 | 2015 | 109 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1491 | 0.110 |
Why?
| | Students | 1 | 2019 | 574 | 0.110 |
Why?
| | Aged | 2 | 2023 | 22083 | 0.110 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5068 | 0.100 |
Why?
| | Biomarkers | 2 | 2024 | 3896 | 0.100 |
Why?
| | Health Promotion | 1 | 2019 | 717 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2021 | 5739 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 1062 | 0.100 |
Why?
| | Premature Birth | 1 | 2015 | 312 | 0.090 |
Why?
| | Young Adult | 3 | 2022 | 12389 | 0.090 |
Why?
| | Insulin | 1 | 2020 | 2320 | 0.080 |
Why?
| | Adult | 5 | 2024 | 35510 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5376 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2715 | 0.060 |
Why?
| | Fibronectins | 1 | 2024 | 120 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2023 | 125 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2024 | 281 | 0.050 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 65 | 0.050 |
Why?
| | Metabolome | 1 | 2024 | 318 | 0.050 |
Why?
| | Iodide Peroxidase | 1 | 2020 | 29 | 0.040 |
Why?
| | Origin of Life | 1 | 2020 | 8 | 0.040 |
Why?
| | Isotopes | 1 | 2020 | 28 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 638 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.040 |
Why?
| | HLA-DR4 Antigen | 1 | 2020 | 78 | 0.040 |
Why?
| | HLA-DR3 Antigen | 1 | 2020 | 80 | 0.040 |
Why?
| | Peroxidase | 1 | 2020 | 169 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 316 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 718 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 757 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 137 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2019 | 155 | 0.040 |
Why?
| | Transglutaminases | 1 | 2019 | 153 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 504 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 245 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2020 | 361 | 0.040 |
Why?
| | Collagen | 1 | 2020 | 429 | 0.040 |
Why?
| | Gestational Age | 1 | 2020 | 868 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2019 | 451 | 0.030 |
Why?
| | Pediatric Obesity | 1 | 2024 | 572 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1180 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 421 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 805 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1167 | 0.030 |
Why?
| | Self Report | 1 | 2020 | 806 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1832 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2024 | 2508 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 176 | 0.030 |
Why?
| | Family Planning Services | 1 | 2015 | 87 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2635 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2015 | 389 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3788 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1209 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 5407 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2015 | 897 | 0.020 |
Why?
| | Smoking | 1 | 2015 | 1466 | 0.020 |
Why?
| | Mice | 1 | 2022 | 16644 | 0.020 |
Why?
| | Middle Aged | 1 | 2024 | 31074 | 0.010 |
Why?
| | Animals | 1 | 2022 | 34600 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|